Search the Newsreel

Xilio Therapeutics Inc (XLO) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Xilio Therapeutics Inc (XLO), allowing users to evaluate the company's financial health. It breaks down operating, investing, and financing cash flows, along with historical data and year-over-year changes. The piece also includes …

Foxx Development Holdings Inc (FOXX) Income Statement

This article provides the quarterly and annual income statements for Foxx Development Holdings Inc (FOXX), offering detailed financial data such as total revenue, operating expenses, net income, and earnings per share. It allows users to analyze the company's financial performance over various periods and …

Xilio Therapeutics Inc (XLO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Xilio Therapeutics Inc (XLO), showing its current stock price, market cap, and P/E. It details revenue by region, specifically highlighting the United States, but notes that relevant data for business segments and current fiscal years have not …

TDAC|TDAC|Price:10.735|Chg%:+0.030

This article provides a detailed company profile for Translational Development Acquisition Corp (TDAC), a blank check company. It outlines TDAC's purpose to effect a business combination, its current operational status, and key financial and executive information. The article lists the company's ticker symbol, IPO …

Marketing Sales Turun, Begini Prospek Saham Ciputra (CTRA) Semester II/2026 - Bisnis.com

Q1 Results: BEL, Coal India, Tata Power, Canara Bank, Indus Towers, HUDCO, Godfrey Phillips India, others to post earnings on July 27; check list

HUDCO Q1 Results: Net profit rises 35% YoY to ₹851 crore, interim dividend announced; check record date

Translational Development Acquisition Secures $50 Million PIPE for ProLogium Merger; 5M Shares Plus Warrants

Housing & Urban Development Corporation consolidated net profit rises 35.05% in the June 2026 quarter

Orissa Minerals net loss narrows 93% to ₹290 lakh in FY26

Translational Development Acquisition Corp. announced that it expects to receive $50 million in funding

Translational Development Acquisition Corp. announced it expects to secure $50 million in funding. This funding will be obtained through a subscription agreement to issue 5,000,000 Class A Ordinary Shares at $10 per share, alongside 5,000,000 Warrants. Naetas Holding Limited is participating as a new …

NB|NioCorp Developments Ltd|Price:5.460|Chg%:+0.100

KRP Development Holdings Limited Revenue Breakdown – HKEX:2421

THE GROUNDS REAL ESTATE DEVELOPMENT AKTIE News | aktuelle Nachrichten | Ticker | A40KXL

NioCorp Developments Ltd (NB) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of NioCorp Developments Ltd (NB) stock information, including its current price, market capitalization, and a section on dividends and stock splits. It states that the company has not distributed any dividends over the past five years and contains no …

Educational Development Corp (EDUC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Educational Development Corp (EDUC), listing its major shareholders and their proportions, including individual investors like Randall Wayne White and institutional holders such as Needham Investment Management. It also provides a historical overview of institutional shareholding changes over …

Educational Development Corp (EDUC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts for Educational Development Corp (EDUC), detailing specific Ex-dividend, Record, and Payment Dates. It indicates that the company has distributed a total of USD 6.56 million in dividends over the past five years. The page also …

THIMAR Development Holding Co. Revenue Breakdown – TADAWUL:4160

DeFi Development Corp. Revenue Breakdown – NASDAQ:DFDV

DeFi Development Corp. (NASDAQ:DFDV) generated $11.39 million USD last year. The Treasury segment was the top performer, contributing $9.19 million USD, with the United States being the primary geographical contributor. These figures indicate key revenue streams and operational focus for the company.

TradingKey

This article provides a detailed quarterly and annual income statement for Xilio Therapeutics Inc. (XLO), including total revenue, operating expenses, net income, and EPS data from Q1 2020 to Q1 2026. It also includes FAQs explaining how to interpret the income statement and defining …

Aran Research & Development (1982) Ltd. Revenue Breakdown – TASE:ARAN

NioCorp Developments Ltd (NB) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for NioCorp Developments Ltd (NB), presenting current stock performance metrics including its closing price, daily change, and market capitalization. It highlights that key valuation ratios like P/E, P/B, and P/CF have not yet been disclosed by the company. …

NioCorp stock delivers 75% return after Fair Value flagged opportunity

NioCorp Developments Ltd. (NB) stock delivered a 75.42% return between May 2024 and July 2026, after InvestingPro's Fair Value models identified it as significantly undervalued. The stock climbed from $2.36 to $4.14, driven by strategic partnerships, government funding, tax incentives, and improved fundamentals including …

NioCorp Developments Ltd (NB) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for NioCorp Developments Ltd (NB), detailing analyst ratings, target prices, and historical EPS performance. Based on 5 analysts, the stock has a "Buy" consensus with a target price of USD 11.62, representing a 166.63% upside. The report also …

Foxx Development Holdings Inc FOXX Balance Sheet

This article provides a detailed balance sheet analysis for Foxx Development Holdings Inc (FOXX), covering quarterly and annual financial statements. It includes key financial metrics such as total equity, cash, receivables, assets, and liabilities, allowing for an evaluation of the company's financial health. The …

NioCorp Developments Ltd (NB) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of NioCorp Developments Ltd (NB) stock, focusing on support, resistance, and various indicator readings. It presents a summary of technical indicators like MACD, RSI, and TRIX, alongside moving averages, to give a "Sell" signal for both indicators and …

Shanghai Zhida Technology Development Co., Ltd. Class H Revenue Breakdown – HKEX:2650

Development Works Food Co. Revenue Breakdown – TADAWUL:6013

EDUC|Educational Development Corp|Price:1.380|

NioCorp Developments Ltd. Revenue Breakdown – NASDAQ:NIOBW

This page provides financial information for NioCorp Developments Ltd. (NASDAQ: NIOBW) on TradingView. It indicates that the market is currently closed and includes sections for financials, documents, news, and community. The page offers a breakdown of revenue by source and country, noting that market …

Embassy Developments Limited Revenue Breakdown – NSE:EMBDL

China Power flags up to 57% profit drop on weaker wind and solar, softer coal demand

Foxx Development Holdings Inc (FOXX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Foxx Development Holdings Inc (FOXX), noting its current valuation score of 9.50, which ranks 10th in the Specialty Retailers industry. It highlights the company's current P/E ratio of -0.37, which is significantly below its recent high but …

Educational Development Corp (EDUC) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Educational Development Corp (EDUC), noting its current valuation score is 8.55, ranking 35th in the Media & Publishing industry. The P/E ratio is 5.34, significantly lower than its recent high but higher than its recent low. The …

Xilio Therapeutics, Inc. (XLO) Stock Price, News, Quote & History

This page provides comprehensive financial information for Xilio Therapeutics, Inc. (XLO), including its current stock price, recent news, historical data, and analyst insights. The company is a clinical-stage biotechnology firm focused on developing masked immuno-oncology therapies. Key financial metrics, performance overview, and comparisons with …

Lobbying Update: $10,000 of NIOCORP DEVELOPMENTS LTD. lobbying was just disclosed

NIOCORP DEVELOPMENTS LTD. (NB) disclosed $10,000 in lobbying expenditures for Q2 2026, focusing on funding and contracts related to NioCorp and US readiness. The article also details recent hedge fund activity in NB stock, with several large institutions increasing their positions, and analyst price …